세계의 라텍스 응집 테스트 키트 시장 규모 조사 및 예측 : 테스트 유형별, 샘플 유형별(혈액, 소변, 뇌척수액, 기타), 최종 사용자별, 지역별 분석(2022-2029년)

Global Latex Agglutination Test Kits Market is valued at approximately USD 447.2 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Latex agglutination test kits are commonly used to detect antibodies or antigens in bodily fluids such as CSF, urine, blood, and saliva. The test kits include antigen or antibody coating on an artificial carrier particle, such as a latex bead. The diverse application areas of latex agglutination test kits, surge in the adoption of point of care (POC) techniques/rapid diagnostics for infectious and autoimmune diseases, coupled with rising government approvals are major driving factors for the market growth across the globe.

The surge in prevalence of infectious and autoimmune diseases is acting as a major catalyzing factor for market growth. According to World Health Organization (WHO) article published in October 2022, tuberculosis (TB) is the 13th biggest cause of death and the second leading infectious disease after COVID-19 (above HIV/AIDS). A total of 10.6 million tuberculosis (TB) cases were anticipated in 2021, with 6.0 million males, 3.4 million women, and 1.2 million children. Thereby, the easing disease burden is fostering the demand for latex agglutination test kits, which, in turn, accelerates market growth at a substantial rate. Moreover, the growing investment in R&D activities, as well as the increasing initiatives by the key market players are presenting various lucrative opportunities over the forecasting years. However, the emergence of new and reliable alternate diagnostics is challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Latex Agglutination Test Kits Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing number of Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories, along with the robust usage of these test kits. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising burden of infectious diseases, geographic expansion of key players, and increasing number of hospital-based laboratories and standalone laboratories in the market space.

Major market players included in this report are:

• Atlas Medical GmbH (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• HiMedia Laboratories (India)
• Pro Lab Diagnostics Inc. (Canada)
• Arlington Scientific, Inc. (U.S.)
• Hardy Diagnostics (U.S.)
• Liofilchem S.r.l. (Italy)
• Biotec (Novacyt) (U.K.)
• Creative Diagnostics (U.S.)

Recent Developments in the Market:

• In July 2022, Bio-Rad Laboratories, Inc. unveiled two products: HAI Negative Run Control for hospital-associated illnesses and Synthetic Negative Run Control for tick-borne, meningitis/encephalitis, and sexually-transmitted infections.

Global Latex Agglutination Test Kits Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Test Type, Sample Type, End-user, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Test Type:

• Antibody Detection
• Antigen Testing

By Sample Type:

• Blood
• Urine
• Cerebrospinal Fluid (Lumbar Puncture)
• Others

By End-user:

• Hospital-based Laboratories
• Standalone Clinical Laboratories

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Latex Agglutination Test Kits Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Latex Agglutination Test Kits Market, by Test Type, 2019-2029 (USD Million)
  • 1.2.3. Latex Agglutination Test Kits Market, by Sample Type, 2019-2029 (USD Million)
  • 1.2.4. Latex Agglutination Test Kits Market, by End-user, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Latex Agglutination Test Kits Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Latex Agglutination Test Kits Market Dynamics

• 3.1. Latex Agglutination Test Kits Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Diverse application areas of latex agglutination test kits
    • 3.1.1.2. Surge in prevalence of infectious and autoimmune diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Emergence of new and reliable alternate diagnostics
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising Introduction of innovative products
    • 3.1.3.2. Increasing initiatives by the key market players

Chapter 4. Global Latex Agglutination Test Kits Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Latex Agglutination Test Kits Market, by Test Type

• 6.1. Market Snapshot
• 6.2. Global Latex Agglutination Test Kits Market by Test Type, Performance - Potential Analysis
• 6.3. Global Latex Agglutination Test Kits Market Estimates & Forecasts by Test Type 2019-2029 (USD Million)
• 6.4. Latex Agglutination Test Kits Market, Sub Segment Analysis
  • 6.4.1. Antibody Detection
  • 6.4.2. Antigen Testing

Chapter 7. Global Latex Agglutination Test Kits Market, by Sample Type

• 7.1. Market Snapshot
• 7.2. Global Latex Agglutination Test Kits Market by Sample Type, Performance - Potential Analysis
• 7.3. Global Latex Agglutination Test Kits Market Estimates & Forecasts by Sample Type 2019-2029 (USD Million)
• 7.4. Latex Agglutination Test Kits Market, Sub Segment Analysis
  • 7.4.1. Blood
  • 7.4.2. Urine
  • 7.4.3. Cerebrospinal Fluid (Lumbar Puncture)
  • 7.4.4. Others

Chapter 8. Global Latex Agglutination Test Kits Market, by End-user

• 8.1. Market Snapshot
• 8.2. Global Latex Agglutination Test Kits Market by End-user, Performance - Potential Analysis
• 8.3. Global Latex Agglutination Test Kits Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
• 8.4. Latex Agglutination Test Kits Market, Sub Segment Analysis
  • 8.4.1. Hospital-based Laboratories
  • 8.4.2. Standalone Clinical Laboratories

Chapter 9. Global Latex Agglutination Test Kits Market, Regional Analysis

• 9.1. Latex Agglutination Test Kits Market, Regional Market Snapshot
• 9.2. North America Latex Agglutination Test Kits Market
  • 9.2.1. U.S. Latex Agglutination Test Kits Market
    • 9.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Sample Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Latex Agglutination Test Kits Market
• 9.3. Europe Latex Agglutination Test Kits Market Snapshot
  • 9.3.1. U.K. Latex Agglutination Test Kits Market
  • 9.3.2. Germany Latex Agglutination Test Kits Market
  • 9.3.3. France Latex Agglutination Test Kits Market
  • 9.3.4. Spain Latex Agglutination Test Kits Market
  • 9.3.5. Italy Latex Agglutination Test Kits Market
  • 9.3.6. Rest of Europe Latex Agglutination Test Kits Market
• 9.4. Asia-Pacific Latex Agglutination Test Kits Market Snapshot
  • 9.4.1. China Latex Agglutination Test Kits Market
  • 9.4.2. India Latex Agglutination Test Kits Market
  • 9.4.3. Japan Latex Agglutination Test Kits Market
  • 9.4.4. Australia Latex Agglutination Test Kits Market
  • 9.4.5. South Korea Latex Agglutination Test Kits Market
  • 9.4.6. Rest of Asia Pacific Latex Agglutination Test Kits Market
• 9.5. Latin America Latex Agglutination Test Kits Market Snapshot
  • 9.5.1. Brazil Latex Agglutination Test Kits Market
  • 9.5.2. Mexico Latex Agglutination Test Kits Market
  • 9.5.3. Rest of Latin America Latex Agglutination Test Kits Market
• 9.6. Rest of The World Latex Agglutination Test Kits Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Atlas Medical GmbH (Germany)
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Thermo Fisher Scientific Inc. (U.S.)
  • 10.2.3. Bio-Rad Laboratories, Inc. (U.S.)
  • 10.2.4. HiMedia Laboratories (India)
  • 10.2.5. Pro Lab Diagnostics Inc. (Canada)
  • 10.2.6. Arlington Scientific, Inc. (U.S.)
  • 10.2.7. Hardy Diagnostics (U.S.)
  • 10.2.8. Liofilchem S.r.l. (Italy)
  • 10.2.9. Biotec (Novacyt) (U.K.)
  • 10.2.10. Creative Diagnostics (U.S.)

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption